Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · May 8, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into a new way to help doctors plan surgery for patients with glioblastoma multiforme, a type of brain cancer. Researchers are using advanced computer technology to analyze brain scans taken before surgery. The goal is to see if this technology can predict how well a patient's tumor will respond to treatment, which could help doctors make better decisions about care.
To participate in this study, you need to be at least 18 years old and have a diagnosis of a brain lesion that looks like glioblastoma multiforme. You’ll need to be planning to have a special brain scan called an MRI before your surgery. Participants can expect to have their MRI analyzed using this new computer algorithm, and they will be asked to sign a consent form to ensure they understand the study. It's important to know that if you cannot have an MRI or if you won't be able to attend follow-up appointments for the study, you may not be eligible. This trial is currently recruiting participants of all genders, and it aims to improve treatment options for patients facing this challenging condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must have a radiological diagnosis of a lesion in the brain with characteristics consistent with glioblastoma multiforme.
- • Must be planning to undergo a pre-operative MRI.
- • Must be at least 18 years old.
- • Must be able to understand and willing to sign an IRB approved written informed consent document.
- Exclusion Criteria:
- • Contraindication to MRI.
- • Inability to have clinical follow-up (e.g., patient is out of town and will do follow-up elsewhere).
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Dimitrios Mathios, M.D.
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported